Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2–16 Years

BACKGROUND: To study the long-term development (104 weeks) of insulin antibodies during treatment with insulin detemir (IDet) and insulin aspart (IAsp) in children with type 1 diabetes aged 2–16 years. METHODS: A 52-week, two-arm, randomized trial comparing IDet and neutral protamine Hagedorn insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Thalange, Nandu, Bereket, Abdullah, Jensen, Lisbeth Bjerring, Hiort, Line Conradsen, Peterkova, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118234/
https://www.ncbi.nlm.nih.gov/pubmed/27600385
http://dx.doi.org/10.1007/s13300-016-0196-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118234/
https://www.ncbi.nlm.nih.gov/pubmed/27600385
http://dx.doi.org/10.1007/s13300-016-0196-5

Ejemplares similares